Wells Fargo cuts Bristol-Myers Squibb stock price target on Eliquis concerns
Related news
- Wall Street searches for direction after bank earnings and tech pressure
- Vision Capital Fund adds GOOGL and DDOG; exits TTD
- Speculative dollar positioning rebounds after midyear pullback
- ServiceNow could be the next software 'accelerator,' BNP Paribas says
- The Cass Index signals a minor freight rebound even as economic headwinds remain
- First Majestic says agrees in principle with Mexico on tax settlement framework
- 2027 has the ‘most negative flow picture’ for equities since 2002 – Paul Tudor Jones
-
Apple releases HomeView smart home hub with screen as showcase for Siri AI